Po-03-196 long-term clinical outcomes of peri-device leak in patients undergoing left atrial appendage occlusion in the amulet ide trial

The Amulet IDE trial is a global, randomized (1:1) trial of the Amplatzer ™ Amulet™ LAA occluder (Abbott) versus the Watchman™ device (Boston Scientific) in patients with non-valvular AF. Patients with a peri-device leak (PDL)> 3mm have shown to be at increased risk for stroke or systemic embolism (SSE) at 18 months. However, longer-term clinical implications from PDL are unclear.

Source: Heart Rhythm - May 1, 2023 Category: Cardiology Authors: Christopher R. Ellis, Dhanunjaya R. Lakkireddy, Stephan Windecker, David Thaler, Nigel Gupta, Alok Gambhir, Jens Erik Nielsen-Kudsk Source Type: research